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Looking different, feeling different: high risk women’s reactions to risk-reducing breast and ovarian surgery  
 
Abstract  
Objectives Most studies of quality of life following risk-reducing bilateral salpingo -oophorectomy (RRSO) and 
mastectomy (RRM) for inherited breast and ovarian cancer susceptibility were conducted before counseling 
protocols were established and included women at varying times since surgery. This study aimed to overcome these 
deficiencies and to provide current data on outcomes for this growing group of women.   
Methods Semi-structured interviews were used to explore the experiences of an Australian cohort of 40 high-risk 
women three years after they underwent RRM and/or RRSO. Data were analyzed using the method of constant 
comparison.  
Results Nineteen women underwent RRSO, 8 RRM and 13 both procedures. Two themes – looking different and 
feeling different - captured the psychosocial impact of surgery upon interviewees. All were relieved at having the 
risk of cancer substantially reduced that had previously been embodied in their breasts and ovaries; however, 
reducing risk by removing these body parts is not without costs. Interviewees reported experiencing a range of 
negative emotions and a range of unexpected bodily sensations following surgery and reflected upon both positive 
and negative changes in their appearance. Women said they had been unprepared for the lack of sensation in 
reconstructed breasts and/or the severity of menopausal symptoms, which often had a negative impact upon 
sexuality.  
Conclusions Although women who undergo RR surgery are informed about its sequelae, however, few are entirely 
prepared for the reality of undergoing this procedure. We recommend that women who undergo these procedures 
should be provided with psychosocial support before and after RR surgery. 
 
Key words: BRCA1 and BRCA2, breast and ovarian cancer, risk-reducing surgery, qualitative, sexuality and body 
image. 
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Introduction  
In about 20-30% of families the occurrence of breast and ovarian cancer in multiple family members is due to a 
germline mutation in the BRCA1 or BRCA2 gene. Between 30-50% of breast cancers that have an inherited 
susceptibility are caused by mutations in the BRCA1 or BRCA2 genes, while as many as 13% of invasive epithelial 
ovarian cancers have a mutation in BRCA1 or BRCA2 independent of family history [1].  
 Although BRCA1 and BRCA2 mutation carriers’ cancer risks are increased [2, 3], evidence suggests that 
these risks can be managed effectively [4-7]. While ovarian screening in high-risk groups is not effective, breast 
cancer screening is indicated and there is evidence of increased sensitivity of magnetic resonance imaging (MRI) for 
detecting malignancies in younger BRCA carriers [8, 9], compared to mammography. Risk-reducing mastectomy 
(RRM) and/or oophorectomy (RRSO) results in a significant decrease in mortality in high-risk women [6, 7, 10, 11]. 
Domcheck et al [11] found that RRSO was associated with lower all-cause mortality, as well as lower breast cancer-
specific and ovarian cancer-specific mortality. Recent data suggest that a combination of RRM and RRSO at 40 
years is the most effective way to improve survival in BRCA mutation carriers, and that performing RRM any earlier 
has little impact upon survival rates [13]. Risk-reducing medication with selective estrogen receptor modulators (e.g. 
tamoxifen) is also an effective way of reducing breast cancer risk [14].  
A number of studies that have investigated the psychosocial sequelae of RR surgery suggest these 
procedures are associated with a decrease in cancer anxiety [15-17]. However, while many women who have RRM 
plus breast reconstruction are pleased with the appearance of their new breasts [18-20], some experience ongoing 
complications following reconstructive surgery [21, 22]; are unhappy with the cosmetic result, particularly the lack 
of sensation in their breasts [22-24]; and report a negative impact upon sexual functioning [15, 22, 25, 26]. Similar 
findings have been reported in studies of RRSO, which indicate that some symptoms of surgically induced 
menopause, primarily hot flushes and loss of libido, are experienced negatively by women who undergo RRSO [27]. 
Bonadies, Moyer, & Matloff [28] suggest that there are gaps in the information that is provided by healthcare 
professionals before surgery. This study found that 60% (3/5) of the most common symptoms experienced by 
women post-surgery were not discussed beforehand [28].  
There are a number of problems with psychosocial research in this area. First, almost all studies have 
collected data using forced choice questions [14, 29, 30], which means that findings are more likely to reflect 
researchers’, rather than patients’, views and perceptions.  Second, the time since surgery in some studies was very 
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variable, indeed, in some cases [21, 31] data was collected many years after surgery, raising the possibility of recall 
bias. Finally, many studies were undertaken before protocols for counseling women about RR surgery were 
established; indeed, in some of the earlier research many women had not received genetic counseling or much 
information prior to surgery [26, 30]. These observations suggest there is a need for up to date research that seeks to 
understand the meaning of these surgical procedures within the wider context of women’s lives and determines 
whether their information needs are now being met.  
 
Methods  
Recruitment 
Participants were recruited from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast 
Cancer (kConFab) Psychosocial study, an 11-year prospective study of over 2,600 women, with no personal history 
of cancer (except non-melanoma skin cancer or cervical intraepithelial neoplasia CIN I-III), but with a strong family 
history of breast and/or ovarian cancer or a documented BRCA1 or BRCA2 mutation [32]. kConFab 
(www.kconfab.org) is a genetic, epidemiological, medical and clinical data resource of individuals at increased 
familial risk of breast cancer across Australia and New Zealand. Eligibility criteria for entry into kConFab have been 
previously published [32].  At the time of enrolment to kConFab, blood is drawn for potential mutation analysis, and 
an epidemiology and family history questionnaire is completed.  Two sub-studies, the Clinical Follow-up Study and 
the Psychosocial Study, are conducted in parallel, collecting clinical follow-up and psychosocial data at three-yearly 
intervals, using self-report questionnaires and a semi-structured interview [33].  
The research reported below was undertaken as part of a larger study investigating psychosocial predictors 
of uptake, and long-term outcomes, of risk-reducing surgery within the kConFab Psychosocial Study cohort.  To be 
eligible for the current study, women had no personal history of cancer (exceptions noted above) at the time of 
cohort enrolment, and subsequently undergone an RRM or RRSO.  Eligible women were invited to participate in a 
telephone interview three years after their risk-reducing surgery.    
Data Collection and Analysis 
This study was approved by the University of Sydney Human Research Ethics Committee and institutional ethics 
committees at each kConFab recruitment site. Semi-structured interviews were conducted from September 2006 to 
January 2009. Open-ended questions focused upon: surgical decision-making, information needs, perceived costs 
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and benefits of surgery, risk perception, pre-surgery expectations and knowledge, experiences of surgery and 
convalescence, menopause and HRT use, and overall satisfaction with the surgical decision. Interviews were audio-
recorded and verbatim transcriptions obtained. 
To determine the meaning of RR surgery in women’s lives, a thematic qualitative analysis was undertaken. 
A subset of transcripts were read by NH, DC, LH and BB and a list of broad categories referring to women’s 
experiences of RR surgery was generated. The transcripts were (re)read in the light of this initial categorization and 
a coding scheme developed using the method of constant comparison [33]. This scheme was used to code the 
remaining transcripts (BB and LH) and was revised as the analysis progressed. Finally, the emergent codes were 
collapsed into higher order themes. A subset of transcripts was independently recoded to determine inter-coder 
concordance. Data was managed using NVIVO8 (Qualitative Solutions & Research Pty Ltd, 2008).  
 
Results 
The participants  
Table 1 here 
Table 1 shows the sociodemographic and medical characteristics of the sample. Forty women who had undergone 
RRSO or RRM between April 2003 and January 2006 (hereafter primary RR surgery) were recruited approximately 
three years later. Eight women had RRM only, 19 RRSO only, and 13 had undergone both procedures (two had both 
types of surgery at the same time and four underwent the second operation within the three year period). The mean 
age at primary surgery was 43 (range 28-66) years. The mean time since primary RR surgery was 37 (range 34-40) 
months. Twenty-five women (63%) carried a BRCA1 or BRCA2 mutation. Thirty-nine (98%) women had one or 
more (range 0-4) first- degree relatives, and 36 (90%) had one or more (range 0-3) second-degree relatives, with 
breast and/or ovarian cancer. 
Nineteen (90%) of the 21 women who had RRM underwent breast reconstruction (15 implants, 4 transverse 
rectus abdominus myocutaneous (TRAM) flap procedure). Of the 32 women who had RRSO, 21 (66%) also had a 
total hysterectomy (not necessarily at the same time). Only six of the 32 (19%) women who had undergone RRSO, 
were post-menopausal prior to surgery (mean age 55 (range 48-61) years).  Eighteen of the 32 (56%) women used 
hormone replacement therapy (HRT) post-oophorectomy, and 14 (44%) were still taking HRT at the time of 
interview.  
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The interview data 
When describing RR surgery women focused upon the way it made them feel and how it affected their appearance, 
thus the data generated two main themes – feeling different and looking different. Some differences were discerned 
regarding the impact of breast versus ovarian surgery and these are highlighted in the analysis. Women who had 
breast surgery only are indicated by the prefix ‘B’, those who had ovarian surgery only ‘O’ and those who had both 
types of surgery ‘BO’. Menopausal status prior to RRSO is indicated for those who underwent RRSO 
(premenopausal (‘premen’)).  
Feeling different  
 
Nearly all interviewees reported being less worried about developing cancer following RR surgery; many used tried 
and trusted metaphors to portray the emotional impact of surgery, describing it as providing “peace of mind” (BO1, 
premen) and the reduction of risk as similar to the eradication  of  “a black cloud” or “the sword of Damocles that 
hovers overhead” (B4).  
While the removal of risky breast/ovarian tissue, and with it the fear about developing cancer, was seen as 
taking positive action, for some women RR surgery generated unforeseen negative emotions. A few described 
“grieving” (O16, premen) for their ovaries (lost fertility) and breasts (“the sadness of not being able to breastfeed” - 
B3). Others experienced negative emotions because they failed to anticipate what losing their breasts or ovaries 
would feel like. In sum, women experienced a range of negative emotions post-surgery including feeling: “grumpy”, 
“angry”, “blue”, “depressed”, “miserable”, “emotional”, “aggressive”, “anxious”, “agitated”, “a bit snaky”, 
“emotional”, “on a downer”, “on an emotional rollercoaster” and “irritable”. 
Many women who had RRSO attributed some of these emotional changes to the menopause, whereas 
participants who underwent RRM saw their negative emotions as a caused by the loss of their breasts. 
B2: I’m not sure what it was but I was extremely emotional. It didn’t last that long but yeah, it was terrible. I 
remember just going to bed and wanting to be up at the dinner table but I had tea and I just had to go and lie down 
and I just cried because I thought I can’t involve myself in anything.  
 
Feeling different – risk-reducing mastectomy  
Unanticipated bodily sensations following RRM were common. Many who had reconstruction reported that their 
breasts felt different - hard and unyielding - and no longer moved in a naturalistic way. Some experienced 
uncomfortable sensations and had to adopt different sleeping positions, while others described their breasts as numb 
or lacking in sensation and their breast implants as feeling alien.  
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B6: They’re just there. I feel like I’ve got a tight bandage wrapped around me all the time. They’re not 
comfortable….they’re just there and you sort of feel all the scar tissue inside …. There is no sensation and you feel 
like you are cold in the chest all the time because they don’t warm up like your normal body does.’ 
 
 A few women said they experienced abdominal numbness or pain after having abdominal tissue removed 
for TRAM flap reconstruction. They described having to be careful of the types of activities they undertook or when 
buying clothes because exercise could pull or clothing could rub against abdominal scars.  
B4: …that section of muscle area across the abdomen and that scar line that’s sort of along the bikini line that 
troubles me at times if I have been lifting a lot of heavy groceries or doing anything particularly sort of physical. 
 
Although most women who had undergone RRM and reconstruction had expected to feel pain after these 
procedures, in some cases the severity and duration of pain was greater than anticipated.  
B3: I knew I’d be in a bit of pain after surgery but I didn’t really realize, I’d never been through that kind of pain 
before so you can’t really prepare for that. 
 
While post-surgical pain was transient, other changing bodily sensations were long-lasting with negative 
psychosocial repercussions. A small group talked about how the (lack of) sensation in their reconstructed breasts had 
negatively affected their sexuality, while others said that until they had adapted to their new breasts, having sexual 
relations had been painful. 
B1: I don’t like my husband touching them (breasts) that much… they don’t feel uncomfortable but it feels like 
you’re touching a rock on you kind of thing and I can’t feel it. 
 
B4:  it was actually very sore, that sort of chest to chest contact, during sex - just my breasts couldn’t take a lot of 
weight on them …. But you just get into different positions.  
 
Feeling different – risk-reducing salpino-oophorectomy 
Those who underwent RRSO described the emotional and sensational impact of menopause upon their lives.  
BO4 (premen): I thought I was going to drop dead at one point….I started getting these real severe sweats and hot 
flushes and the insomnia set in and it was like somebody had thrown a brick at me. You know one day I’m fine and 
then the next day it’s a totally different story.  
 
While a couple of women were positive about cessation of menstruation and menstrual symptoms, most 
reported multiple negative symptoms including: hot flushes, incontinence, excess hair, night sweats, weight gain, 
lack of libido, vaginal dryness/pain during intercourse, anxiety/panic, forgetfulness, heart palpitations, shakiness, 
“creepy crawly skin”, mood swings, depression, dry skin, insomnia, and headaches.  
Some women who were pre-menopausal prior to RRSO had few expectations about the actual symptoms of 
menopause; others reported being very well-informed, but nearly all had expected some mood swings and hot 
flushes and some impact on their sexuality. However, few women who were pre-menopausal before RRSO reported 
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being prepared for either the severity of menopausal symptoms (particularly, hot flushes) or their speed of onset. As 
O10 (premen) commented, “I was aware of what to expect …but the severity of it I did not understand.” Indeed, the 
consensus regarding surgical menopause was despite being aware of what could happen “…you really don’t know 
until you’re going through it” (O9, premen).  
Participants expressed uncertainty about the use of HRT. Unanticipated issues included: the difficulties 
balancing hormone levels, experiencing side-effects, HRT that did not work and confusion before and after surgery 
about whether to use HRT. Few knew what to expect from HRT, how long it would take to work or how long to use 
it. 
BO5 (premen): Well I would have liked to have known what HRT was…all the different types of HRT, the fact that 
one doesn’t suit everybody, different dosages, different brands even affect different people differently.  Um I guess I 
still have even unanswered questions like I’m in my 40s now, do I need to take this forever or what.  
 
These uncertainties led to some participants not using HRT or other alternatives.  
O8 (premen): …I would have liked to have known more about the alternatives (to HRT) for high-risk women…five 
years down the track I really don’t know how…I really don’t know but I just don’t take it because that’s what I 
believe.  
 
Women who had RRSO commented upon the negative effect on their sexuality. Some talked about vaginal 
dryness and how painful intercourse had become since surgery. As O9 (premen) said, “It is just the pain side of it, I 
didn’t realize how dry you would be and I just felt like that, my husband’s changed towards it as well”.  Others 
talked about their lack of libido post-oophorectomy.  
O8 (premen):…more than just a lack of libido, it’s complete, complete disinterest, you know complete – I don’t 
know how to put it, …..I don’t think that they really tell you strongly enough that it’s a complete disinterest.  
 
 Although many had anticipated that RRSO would impact on their libido, they had not expected these 
symptoms to be so profound or long-lasting. For some their lack of sexual desire was experienced as having 
profoundly negative implications for their identity.  
O19 (premen):...it’s a shame that they can (remove your ovaries) and they can’t replace the estrogen or whatever 
that gives you that sexual drive... I mean you’ve lost your bits and pieces but then you lose that thing that makes you 
feel like a woman.  
 
Thus, in contrast to women who had undergone RRM, who reported feeling more feminine following 
surgery, some RRSO participants experienced RR surgery and the accompanying impact on their sexuality as having 
a negative impact on gender identity. 
BO4 (premen): with the mastectomy I didn’t feel as feminine as I didn’t have my breasts, but with the hysterectomy 
and the ovaries - that really affected me. I’ve got to admit that truly affected me. I just thought that was the only 
woman bit I had left. 
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In summary, the data suggest that many women feel differently about their bodies following RR surgery. 
Most felt less anxious about the risk of cancer in their breasts and ovaries; however reducing risk by removing 
breasts and ovaries was acknowledged as carrying a number of costs. Women reported experiencing a range of 
negative emotions and a series of new, and mainly negative, bodily sensations following surgery. While many of 
these changes had been anticipated, it was clear that their intensity and duration had surprised many interviewees.  
Looking different – risk-reducing mastectomy  
While surgery generated some unexpected feelings, it also impacted on the way one looked. Women who had RRM 
plus reconstruction often described visible improvements. The opportunity to change breast shape and size with 
reconstruction following RRM was described as a bonus. “I ended up with a better bust than I had before so I was 
happy” (B5). All those who had RRM had ended up with firmer breasts and many talked about how they could wear 
more skimpy, or sexy, clothing. 
B7: I love it now because I mean it’s just sort of, I could go without a bra if I wanted to because I don’t… like I’ve 
never not been able to wear a bra, I was a double D cup, so I went to a C cup and I can go in a singlet without having 
to wear a bra because they’re not sort of… they’re like when I was 20 again. 
 
 For a small group, TRAM flap reconstruction also involved an incidental bonus. As BO14 (menopausal), 
said: “I had a very big bust and so I got it reduced. Plus I got a tummy tuck into the bargain”. However, some were 
distressed by the cosmetic results, like BO1: “I’ve got this train track that goes right across my breast”, or the 
different shape of their breasts. Finding clothing to cover the scars was difficult for some, while others said their 
breasts sat differently, constraining their wardrobe choices. 
 Many women were conscious of both breast and abdominal scarring following TRAM flap breast 
reconstruction, and a couple said that they no longer liked their reflection in the mirror. In general, abdominal 
scarring was not regarded as so much of a problem as breast scarring. It took time for many women to get used to 
the look of their new body. Those who had breast implants felt self-conscious at first and commented that their 
breasts did not sit properly on their chest. Others just did not like the look of their implants, including the way they 
moved; as B6 said “they’re not attractive, they are ugly.”  
Some RRM women regretted not having nipple reconstruction. As B4 said “like standing naked in front of 
the mirror it’s sort of okay, well they’re a nice shape but it would be really nice if I still had nipples”. B3 reported 
that not having nipples had affected her sexuality as she did not like her partner seeing her naked anymore. Finally, 
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one woman who had not had reconstructive surgery still found it difficult to accept the look of her mastectomized 
body.  
BO2 (premen): … my kids say they don’t know whether I’m wearing it [prosthesis] or not …. I still have those 
things where they assure me that everything is perfectly okay and my husband still adores me and everything and 
that’s wonderful, but it’s in my head still, that hang on I made this decision and I really, I think I look really 
different.  
 
Finally, there was evidence that while most women were prepared for changes in their appearance post-
surgery, their expectations were not always met. While some were pleasantly surprised, like BO5 (premen), “I had 
not expected the reconstruction to turn out as good as it had. I’m really pleased with it,” many were still distressed 
about scarring, and the actual changes were of a greater magnitude, or more long-lasting, than expected. BO1 
(premen): “I hadn’t expected them [breasts] to sort of look like you know, as I said I didn’t expect the scarring to 
still be there.”  
 
Looking different – risk-reducing salpino-oophorectomy  
While gross differences in the visibility of RRM and RRSO were recognized in these accounts “with the ovaries 
there was the keyhole surgery, you’re in and out really quickly and you don’t look any different when you walked 
out of the hospital… whereas obviously the mastectomy was a much bigger operation… like everybody can see” 
(BO1, premen).  There was an acknowledgement that RSSO still wrought subtle changes upon the body, while 
scarring  was less of an issue for this group, many reflected upon post-surgical weight gain and how their body 
shape, especially fat distribution, had changed. As O3 said about her weight gain: “I’m getting a little bit – a tiny 
little bit of a tummy, like I said I’ve always been very athletic and very slim." Other women were very negative 
about this effect of surgery describing post-surgical weight gain as making them feel less attractive. O16: “…putting 
on the weight…different shape…. I don’t know if it affects my life, it just makes me feel less attractive...”  
However, in the main these bodily changes were anticipated and regarded as physical transformations that would 
have occurred naturally with time.  
Feeling and looking different  
As O16’s comments (above) suggest, this analysis draws a somewhat artificial distinction between how women feel 
following RR surgery and how they look, for it is apparent that in many cases how these women felt about 
themselves was clearly related to how they looked. Many talked about how surgery had affected their identity. B2, 
for example, had feared her gender identity would be compromised by RRM, but found the opposite occurred:  
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B2: You probably expect part of your womanhood as such being taken away, but I actually feel so much more a 
woman now…while my breasts aren’t perfect I’m very happy with what I’ve got…and I just feel a lot more 
confident in myself. 
 
In contrast, BO11 described still trying to come to terms with surgery and actively having to try to 
incorporate the look of her new body into her identity.  
BO11 (premen): I call them brumps, they’re not really breasts and not really lumps so …Whatever they are...I went 
back last year and had some nipples [constructed] …I’ll probably have the tattoos done...it is ongoing but I am going 
to persevere with it and try and make myself feel like they’re a part of me.  
 
Indeed, for most interviewees, the impact of surgery on their emotional life and appearance were intimately related 
for better or worse.  
 
 
 
Discussion 
This study found that women who undergo risk-reducing breast and/or ovarian surgery to reduce their risk of cancer, 
experience a range of positive and negative psychosocial consequences. Like previous research, this study suggests 
that women who undergo RR surgery have a positive emotional response to the reduction in their breast and/or 
ovarian cancer risk [25, 35] and often like the look of their reconstructed breasts [18-20]. However, they also 
described a range of negative psychosocial sequelae associated with these surgical procedures. Although the 
majority underwent these procedures with a number of expectations about how the surgery might affect them, the 
findings reveal that the impact of surgery had surpassed their expectations in many ways. 
Many of the women who underwent RRM plus reconstruction commented on the numbness, pain and 
discomfort they experienced as a result of surgery, and described how these sensations negatively affected their 
everyday activities (sleeping, moving around, sport) as well as their sexuality [36] and body image. While earlier 
studies suggest that sexual functioning is not compromised by RRM, there is evidence that about half of the women 
who undergo this procedure report some issues with body image and sexuality [15, 19, 21], like the women in this 
study. Our study suggests that while many of our interviewees had some expectations of how their breasts might 
look post-surgery, few had any realistic expectations about the changes in sensation in their breasts, changes which 
were uniformly experienced as disturbing. 
There was evidence that the premenopausal women who underwent RRSO were relatively well-informed 
about some of the menopausal symptoms they might experience post-surgery (e.g. hot flushes and loss of libido); 
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however, their intensity and speed of onset was not anticipated. Indeed, many women were shocked at their lack of 
libido following RRSO. These observations support the findings of a recent study, which found that nearly 60% of 
BRCA carriers who had undergone RRSO would have liked more information about the impact on their sex lives 
and to be given the option of sex counseling [28]. While many of our interviewees reported that they had expected to 
look different after ovarian surgery - they had expected scarring (particularly following TAH) and anticipated that 
they might gain weight following RRSO - few accurately predicted the magnitude of these changes or the impact on 
body image. This was particularly true for those women who had been pre-menopausal before surgery.  
 
Strengths and Limitations 
The strength of the current study is that all participants were interviewed at the same time point - three years after 
surgery. As a result, while the data may be tainted by hindsight, the impact of time on recall is constant and any 
inconsistencies in the reporting of experiences that arise due to variations in the women’s location on the recovery 
trajectory are minimized. Moreover, as all had undergone surgery during the same time period, any guidelines on 
how to provide information or support, e.g. [37] were consistent across our sample. These strengths address a 
limitation of earlier studies in this area that have investigated the consequences of RR surgery at varying time points 
after surgery [21, 31]. 
However, as with all research of this type there is a potential that this study includes a biased sample; that 
only those who had polarized issues around surgery may have consented to be interviewed. It is also possible that 
there is something significant about the three-year post-surgery time point at which these women were interviewed. 
Bearing this in mind we suggest that future research should adopt a longitudinal design, in which women are 
interviewed at different time points to determine changes in their experiences and attitudes. 
Clinical implications 
This study suggests that while many women correctly anticipate many of the visible sequelae of risk-reducing 
surgery, it is also apparent that many remain unprepared for the changes in the way their bodies feel [21, 24, 26, 36] 
and the ways they may feel about themselves [15, 21, 25, 27, 38] following surgery. While health care professionals 
may do their best to prepare women for physical changes, pain, scarring and reduced libido, there is evidence that 
the impact upon sexuality, body image and gender identity are not routinely discussed by surgeons and, in line with 
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recommendations made in recent papers [28], we argue that these issues are important topics for discussion in pre-
operative consultations.  
Before proposing recommendations for clinical practice, we want to draw attention to the fact that all health 
professionals involved in the care of high-risk women, including those working in familial cancer clinics, breast 
surgeons and/or gynecologists, need to be forthcoming in explaining RR surgery and its psychosocial after-effects. It 
cannot be assumed that health professionals who have had previous contact with a woman have adequately 
addressed this area.  
First, women need to know that reconstructed breasts may look better, but alternatively could look worse 
than their original breasts, and may, in either case, feel very different, particularly if implants are used. The South 
Australia Familial Cancer Clinic has developed an information leaflet about this which graphically describes the 
shape, sensation of reconstructed breasts and how this may impact on one’s life and sexuality [39]. Similar 
information should be given to all those who undergo this procedure.  
Second, women need to be encouraged to consider the impact that both types of RR surgery may have on 
their sexuality and/or gender identity, as these impacts, in particular, may have ongoing and negative implications 
for their relationships. They need to be proactively provided with strategies to facilitate sexual adjustment should 
difficulties ensue. 
Third, women need more information about surgical menopause, what it may feel like and how fast the 
symptoms present following RRSO. Notably, young women in their thirties and early forties are unlikely to have 
discussed menopause with their peers, and in many of these families women in older generations have not survived 
long enough to go through a natural menopause; therefore the information about symptoms, what they feel like or 
their impact,  may not be passed down from mother to daughter. The risk of other adverse effects, such as cognitive 
impairment in women undergoing RRSO prior to menopause, should also be discussed [40]. Women also need 
information about the costs and benefits of HRT. Indeed, recent research suggests HRT may be beneficial not only 
for alleviating menopausal symptoms, but also in preventing bone loss, and promoting cardiovascular health  in 
women who have undergone RRSO under 50 years of age [41]. 
Finally, women should be warned that RRSO may have as much, if not more, of an impact than RRM. 
While ovarian surgery may result in less obvious and immediate outward changes to women’s bodies, its ongoing 
detrimental effect on women’s lives can be equally, if not more, profound. We suggest that younger premenopausal 
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women who are considering RRSO should be offered a clinical psychological consultation as is current practice for 
women who are contemplating RRM. 
But not only is improved pre-surgical counseling indicated, our data suggest that up to three years after 
surgery women may still be adjusting to these procedures and therefore, may also benefit from long-term 
psychosexual follow-up. Familial cancer clinics, which provide long-term follow up for these high risk families, 
may be best-placed to provide such a service.  
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Table 1: Participant characteristics (N=40) 
      
 RRM  
N=8 (20%) 
RRSO  
N=19 (48%) 
RRM+RRSO = 13 
(33%) 
Total = 40 (100%) 
AGE AT PRIMARY RR 
SURGERY years  
mean (range) 
34 (28-41) 44 (33-61) 46 (32-66) 43 (28-66) 
 
MARITAL STATUS 
Married / de facto 
No current partner 
 
6 (75) 
2 (25) 
 
19 (100) 
0 (0) 
 
10 (77) 
3 (23) 
 
35 (88) 
5 (13) 
CHILDREN (yes) 
Boys only 
Girls only 
Both 
6 (75) 18 (95) 11 (85) 35 (88) 
3 (38) 1 (5) 3 (23) 7 (18) 
0 (0) 7 (37) 2 (15) 9 (23) 
3 (38) 10 (53) 6 (46) 19 (48) 
EMPLOYMENT  
Employed 
Domestic duties  
Retired / Invalid 
Student  
 
4 (50) 
 
17 (90) 
 
6 (47) 
 
27 (68) 
2 (25) 1 (5) 3 (23) 6 (15) 
0 (0) 1 (5) 3 (23) 4 (10) 
2 (25) 0 (0) 1 (8) 3 (8) 
HIGHEST EDUCATION 
ACHIEVED 
Secondary Education 
Vocational training 
University graduate  
 
 
2 (25) 
 
 
10 (53) 
 
 
7 (54) 
 
 
19 (48) 
3 (38) 9 (47) 1 (8) 13 (33) 
3 (38) 0 (0) 5 (38) 8 (20) 
FAMILY HISTORY 
FDR/SDR breast cancer 
FDR/SDR ovarian cancer 
 
8 (100) 
2 (25) 
 
19 (100) 
7 (37) 
 
13 (100) 
8 (62) 
 
40 (100) 
17 (89) 
HRT use 
Never 
Before surgery 
After surgery 
At time of interview 
 
8 (100) 
 
9 (47) 
 
2 (15) 
 
19 (48) 
0 (0) 1 (5) 2 (15) 19 (48) 
0 (0) 9 (47) 9 (69) 13 (33) 
0 (0) 6 (32) 8 (62) 8 (20) 
 
